Anemia is common among people living with HIV infection and is frequently associated with poor quality of life and poor prognosis. It has been well described in antiretroviral naïve individuals and those on non-nucleoside reverse transcriptase inhibitor-based first line antiretroviral therapy (ART) regimens. However there is limited information on anemia for ART experienced individuals on protease inhibitor-based second line ART regimens in resource limited settings. Our objective was to describe the prevalence and risk factors of anemia in this ART experienced population in Malawi.
We conducted a cross-sectional study using routine facility data at two HIV clinics in Lilongwe, Malawi. The analysis included individuals receiving protease inhibitor-based second line ART. Clinical and laboratory data were collected at routine clinic visits. We used descriptive statistics, two-sample t-tests and multivariate logistic regression for data analysis.
Three hundred seventy-seven records were included in this analysis (37% male, median age 41 years, median CD4 count 415 cells/μL). The prevalence of anemia was 125/377 (33.2%) − mild, moderate and severe anemia was 17.5%, 13.8%, and 1.9% respectively. Female participants had a higher prevalence than male participants (43.6% vs. 15.7%, p < 0.001). In multivariate logistic regression, female sex (adjusted odds ratio (aOR) 5.3; 95% CI 2.9–9.5) and a CD4 count <200 cell/ul (aOR 3.1; 95%CI 1.6–6.0) were associated with increased risk of having anemia while a BMI ≥30 kg/m2 (aOR 0.8; 95% CI 0.6–1.0) and being on ART for more than 10 years (aOR 0.4; 95% CI 0.2–0.9) were associated with reduced risk of anemia. Being on a zidovudine- containing ART regimen was not associated with anemia.
Anemia is common in people on second line ART in Lilongwe, Malawi. Screening for anemia in this population would be a useful strategy; especially for female patients, those who are underweight and have a low CD4 cell counts.
World Health Organization. Worldwide prevalence of anemia 1993–2005: WHO global database on anemia. Geneva, Switzerland: WHO; 2008. http://www.who.int/nutrition/publications/micronutrients/anaemia_iron_deficiency/9789241596657/en/. Accessed 8 October 2016
Sullivan PS, Hanson DL, Chu SY, Jones JL, Ward JW. Epidemiology of anemia in human immunodeficiency virus (HIV)-infected persons: results from the multistate adult and adolescent spectrum of HIV disease surveillance project. Blood. 1998;91:301–8. PubMed
Redig AJ, Berliner N. Pathogenesis and clinical implications of HIV-related anemia in 2013. Hematol Am Soc Hematol Educ Program. 2013;2013:377–81.
Berhane K, Karim R, Cohen MH, Masri-Lavine L, Young M, Anastos K, Augenbraun M, Watts DH, Levine AM. Impact of highly active antiretroviral therapy on anemia and relationship between anemia and survival in a large cohort of HIV-infected women: Women's interagency HIV study. J Acquir Immune Defic Syndr. 2004;37:1245–52. CrossRefPubMed
Denue BA, Kida IM, Hammagabdo A, Dayar A, Sahabi MA. Prevalence of anemia and immunological markers in HIV-infected patients on highly active antiretroviral therapy in northeastern Nigeria. Infect Dis. 2013;6:25–33.
Hosseinipour MC, van Oosterhout JJ, Weigel R, Phiri S, Kamwendo D, Parkin N, et al. The public health approach to identify antiretroviral therapy failure: high-level nucleoside reverse transcriptase inhibitor resistance among Malawians failing first-line antiretroviral therapy. AIDS (London, England). 2009;23(9):1127–34. CrossRef
Ministry of Health. Malawi Ministry of Health Integrated HIV Program Report April–June 2016. 2016. 1–37 p.
Ministry of Health and Population and National AIDS Commission. Clinical management of HIV/AIDS in children and adults. Third ed. Lilongwe, Malawi: MOH; 2014.
World Health Organization. Hemoglobin concentrations for the diagnosis of anemia and assessment of severity. 2011. http://www.who.int/vmnis/indicators/haemoglobin/en/. Accessed on 5 June 2016.
World Health Organization. WHO case definitions of HIV for surveillance and revised clinical staging and immunological classification of HIV-related disease in adults and children. 2006. http://www.who.int/hiv/pub/vct/hivstaging/en/. Accessed on 5 June 2016.
World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. 2016. http://www.who.int/hiv/pub/arv/arv-2016/en/. 15 December 2016.
Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Annals of Internal Medicine. 130(6):461–70.
Moore RD, Keruly JC, Chaisson RE. Anemia and survival in HIV infection. JAcquir immune Defic Syndr hum. Retrovirology. 1998;19:29–33.
Ministry of Health, Malawi, UNICEF/CDC Report of the National Micronutrient Survey. 2001.
National Statistical Office (NSO) and ICF Macro. 2016. Malawi Demographic and Health Survey 2015. Zomba, Malawi, and Calverton, Maryland, USA: NSO and ICF Macro.
Johannessen A, Naman E, Gundersen S, Bruun J. Antiretroviral treatment reverses HIV-associated anemia in rural Tanzania. BMC Infect Dis. (2011;11(190)
Gedefaw L, Yemane T, Sahlemariam Z, Yilma D. Anemia and risk factors in HAART Naïve and HAART experienced HIV positive persons in south West Ethiopia: a comparative study. PLoS One. 2013;8
Kupka R, Msamanga GI, Mugusi F, et al. Iron status is an important cause of anemia in HIV-infected Tanzanian women but is not related to accelerated HIV disease progression. J Nutr. 2007;137(10):2317–23. PubMed
Stoltzfus R., Dreyfus M.L. Guidelines for the use of iron supplements to prevent and treat iron deficiency anemia. Edited by INACG, WHO and UNICEF. IUNACG. Washington.1998.
E, Brentlinger Paula, Silva Wilson P, Vermund Sten, Valverde Emilio, Buene Manuel, Moon Troy D. 2015. "Practical Management of HIV-Associated Anemia in Resource-Limited Settings: Prospective Observational Evaluation of a New Mozambican Guideline." AIDS research and human retroviruses.
- Anemia in people on second line antiretroviral treatment in Lilongwe, Malawi: a cross-sectional study
Nora E. Rosenberg
Christopher C. Stanley
Mina C. Hosseinpour
- BioMed Central
Neu im Fachgebiet Innere Medizin
Meistgelesene Bücher aus der Inneren Medizin
e.Med Kampagnen-Visual, Mail Icon II